These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

191 related articles for article (PubMed ID: 29435815)

  • 1. Nerve Ultrasound Predicts Treatment Response in Chronic Inflammatory Demyelinating Polyradiculoneuropathy-a Prospective Follow-Up.
    Härtig F; Ross M; Dammeier NM; Fedtke N; Heiling B; Axer H; Décard BF; Auffenberg E; Koch M; Rattay TW; Krumbholz M; Bornemann A; Lerche H; Winter N; Grimm A
    Neurotherapeutics; 2018 Apr; 15(2):439-451. PubMed ID: 29435815
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Differentiation Between Guillain-Barré Syndrome and Acute-Onset Chronic Inflammatory Demyelinating Polyradiculoneuritis-a Prospective Follow-up Study Using Ultrasound and Neurophysiological Measurements.
    Grimm A; Oertl H; Auffenberg E; Schubert V; Ruschil C; Axer H; Winter N
    Neurotherapeutics; 2019 Jul; 16(3):838-847. PubMed ID: 30756363
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Ultrasound pattern sum score, homogeneity score and regional nerve enlargement index for differentiation of demyelinating inflammatory and hereditary neuropathies.
    Grimm A; Vittore D; Schubert V; Lipski C; Heiling B; Décard BF; Axer H
    Clin Neurophysiol; 2016 Jul; 127(7):2618-24. PubMed ID: 27291881
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Nerve ultrasound as follow-up tool in treated multifocal motor neuropathy.
    Rattay TW; Winter N; Décard BF; Dammeier NM; Härtig F; Ceanga M; Axer H; Grimm A
    Eur J Neurol; 2017 Sep; 24(9):1125-1134. PubMed ID: 28681489
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Ultrasound aspects in therapy-naive CIDP compared to long-term treated CIDP.
    Grimm A; Vittore D; Schubert V; Rasenack M; Décard BF; Heiling B; Hammer N; Axer H
    J Neurol; 2016 Jun; 263(6):1074-82. PubMed ID: 27017343
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Axonal damage determines clinical disability in chronic inflammatory demyelinating polyradiculoneuropathy (CIDP): A prospective cohort study of different CIDP subtypes and disease stages.
    Grüter T; Motte J; Bulut Y; Kordes A; Athanasopoulos D; Fels M; Schneider-Gold C; Gold R; Fisse AL; Pitarokoili K
    Eur J Neurol; 2022 Feb; 29(2):583-592. PubMed ID: 34687104
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Bochum ultrasound score allows distinction of chronic inflammatory from multifocal acquired demyelinating polyneuropathies.
    Kerasnoudis A; Pitarokoili K; Gold R; Yoon MS
    J Neurol Sci; 2015 Jan; 348(1-2):211-5. PubMed ID: 25534358
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Increased muscle echointensity correlates with clinical disability and muscle strength in chronic inflammatory demyelinating polyneuropathy.
    Fisse AL; Fiegert S; Stoykova Z; Brünger J; Athanasopoulos D; Grüter T; Motte J; Gold R; Pitarokoili K
    Eur J Neurol; 2021 May; 28(5):1698-1705. PubMed ID: 33404183
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Nerve size in chronic inflammatory demyelinating neuropathy varies with disease activity and therapy response over time: a retrospective ultrasound study.
    Zaidman CM; Pestronk A
    Muscle Nerve; 2014 Nov; 50(5):733-8. PubMed ID: 24615614
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Nerve echogenicity and intranerve CSA variability in high-resolution nerve ultrasound (HRUS) in chronic inflammatory demyelinating polyneuropathy (CIDP).
    Fisse AL; Pitarokoili K; Motte J; Gamber D; Kerasnoudis A; Gold R; Yoon MS
    J Neurol; 2019 Feb; 266(2):468-475. PubMed ID: 30554264
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The value of MUNIX as an objective electrophysiological biomarker of disease progression in chronic inflammatory demyelinating polyneuropathy.
    Okhovat AA; Advani S; Ziaadini B; Panahi A; Salehizadeh S; Nafissi S; Haghi Ashtiani B; Rajabally YA; Fatehi F
    Muscle Nerve; 2022 Apr; 65(4):433-439. PubMed ID: 35040150
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Clinical, Sonographic, and Electrophysiologic Longitudinal Features of Chronic Inflammatory Demyelinating Polyneuropathy.
    Fisse AL; Pitarokoili K; Trampe N; Motte J; Kerasnoudis A; Gold R; Yoon MS
    J Neuroimaging; 2019 Mar; 29(2):223-232. PubMed ID: 30407676
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Retrospective analysis of response to rituximab in chronic inflammatory demyelinating polyneuropathy refractory to first-line therapy.
    Fatehi F; Okhovat AA; Panahi A; Ziaaddini B; Rajabally YA; Nafissi S
    J Peripher Nerv Syst; 2021 Dec; 26(4):469-474. PubMed ID: 34469032
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Changes of clinical, neurophysiological and nerve ultrasound characteristics in CIDP over time: a 3-year follow-up.
    Fionda L; Di Pasquale A; Morino S; Leonardi L; Vanoli F; Loreti S; Garibaldi M; Lauletta A; Alfieri G; Bucci E; Salvetti M; Antonini G
    J Neurol; 2021 Aug; 268(8):3011-3019. PubMed ID: 33638679
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Heterogeneity of root and nerve ultrasound pattern in CIDP patients.
    Padua L; Granata G; Sabatelli M; Inghilleri M; Lucchetta M; Luigetti M; Coraci D; Martinoli C; Briani C
    Clin Neurophysiol; 2014 Jan; 125(1):160-5. PubMed ID: 24099922
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Long-term neurophysiological and clinical response in patients with chronic inflammatory demyelinating polyradiculoneuropathy treated with subcutaneous immunoglobulin.
    Cirillo G; Todisco V; Tedeschi G
    Clin Neurophysiol; 2018 May; 129(5):967-973. PubMed ID: 29554579
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Peripheral nerve ultrasound changes in CIDP and correlations with nerve conduction velocity.
    Di Pasquale A; Morino S; Loreti S; Bucci E; Vanacore N; Antonini G
    Neurology; 2015 Feb; 84(8):803-9. PubMed ID: 25632087
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Blink R1 latency utility in diagnosis and treatment assessment of polyradiculoneuropathy-organomegaly-endocrinopathy-monoclonal protein-skin changes and chronic inflammatory demyelinating polyradiculoneuropathy.
    Wang W; Litchy WJ; Mauermann ML; Dyck PJB; Dispenzieri A; Mandrekar J; Dyck PJ; Klein CJ
    Muscle Nerve; 2018 Jan; 57(1):E8-E13. PubMed ID: 28646568
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Chronic inflammatory demyelinating polyradiculoneuropathy: can a diagnosis be made in patients not fulfilling electrodiagnostic criteria?
    Liberatore G; Manganelli F; Doneddu PE; Cocito D; Fazio R; Briani C; Filosto M; Benedetti L; Mazzeo A; Antonini G; Cosentino G; Jann S; Cortese A; Marfia GA; Clerici AM; Siciliano G; Carpo M; Luigetti M; Lauria G; Rosso T; Cavaletti G; Santoro L; Peci E; Tronci S; Ruiz M; Cotti Piccinelli S; Schenone A; Leonardi L; Toscano A; Mataluni G; Spina E; Gentile L; Nobile-Orazio E;
    Eur J Neurol; 2021 Feb; 28(2):620-629. PubMed ID: 32959475
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Comparison of high-frequency and ultrahigh-frequency probes in chronic inflammatory demyelinating polyneuropathy.
    Puma A; Azulay N; Grecu N; Suply C; Panicucci E; Cambieri C; Villa L; Raffaelli C; Sacconi S
    J Neurol; 2019 Sep; 266(9):2277-2285. PubMed ID: 31175432
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.